Clinical Trial Update: Leflunomide in Patients With PTEN-Altered Advanced Solid Malignancies and HER2 Negative Breast Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating leflunomide in patients with PTEN-altered advanced solid tumors and HER2-negative breast cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Leflunomide (Leflunomide)

Snippet

Sponsor: Deborah Doroshow | Conditions: PTEN-Altered Advanced Solid Tumors and HER2 Negative Breast Cancer | Phase 1 | Status: RECRUITING